|
Borisov S, Danila E, Maryandyshev A, Dalcolmo M, Miliauskas S, Kuksa L, Manga S, Skrahina A, Diktanas S, Codecasa LR, Aleksa A, Bruchfeld J, Koleva A, Piubello A, Udwadia ZF, Akkerman OW, Belilovski E, Bernal E, Boeree MJ, Cadinanos Loidi J, Cai Q, Cebrian Gallardo JJ, Dara M, Davidaviciene E, Forsman LD, De Los Rios J, Denholm J, Draksiene J, Duarte R, Elamin SE, Escobar Salinas N, Ferrarese M, Filippov A, Garcia A, Garcia-Garcia JM, Gaudiesiute I, Gavazova B, Gayoso R, Gomez Rosso R, Gruslys V, Gualano G, Hoefsloot W, Jonsson J, Khimova E, Kunst H, Laniado-Laborin R, Li Y, Magis-Escurra C, Manfrin V, Marchese V, Martinez Robles E, Matteelli A, Mazza-Stalder J, Moschos C, Munoz-Torrico M, Mustafa Hamdan H, Nakceriene B, Nicod L, Nieto Marcos M, Palmero DJ, Palmieri F, Papavasileiou A, Payen MC, Pontarelli A, Quiros S, Rendon A, Saderi L, Smite A, Solovic I, Souleymane MB, Tadolini M, van den Boom M, Vescovo M, Viggiani P, Yedilbayev A, Zablockis R, Zhurkin D, Zignol M, Visca D, Spanevello A, Caminero JA, Alffenaar JW, Tiberi S, Centis R, D'Ambrosio L, Pontali E, Sotgiu G, Migliori GB. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report. Eur Respir J. 2019 Dec 19;54(6):1901522. doi: 10.1183/13993003.01522-2019. Print 2019 Dec. PubMed PMID: 31601711.
AÑO: 2019; IF: 12.339
|
|
Perez AB, Vrancken B, Chueca N, Aguilera A, Reina G, Garcia-Del Toro M, Vera F, Von Wichman MA, Arenas JI, Tellez F, Pineda JA, Omar M, Bernal E, Rivero-Juarez A, Fernandez-Fuertes E, de la Iglesia A, Pascasio JM, Lemey P, Garcia F, Cuypers L. Increasing importance of European lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain. Euro Surveill. 2019 Feb;24(9):1800227. doi: 10.2807/1560-7917.ES.2019.24.9.1800227. PubMed PMID: 30862327; PubMed Central PMCID: PMC6402173.
AÑO: 2019; IF: 6.454
|
|
Rosado-Sanchez I, Rodriguez-Gallego E, Peraire J, Vilades C, Herrero P, Fanjul F, Gutierrez F, Bernal E, Pelazas R, Leal M, Veloso S, Lopez-Dupla M, Blanco J, Vidal F, Pacheco YM, Rull A. Glutaminolysis and lipoproteins are key factors in late immune recovery in successfully treated HIV-infected patients. Clin Sci (Lond). 2019 Apr 29;133(8):997-1010. doi: 10.1042/CS20190111. Print 2019 Apr 30. PubMed PMID: 30952809.
AÑO: 2019; IF: 5.223
|
|
Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillen M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadinanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidaviciene E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, Garcia-Garcia JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborin R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martinez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quiros S, Rendon A, Skrahina A, Smite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stosic M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study. Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3. PubMed PMID: 30953827.
AÑO: 2019; IF: 3.202
|
|
Valero Cifuentes S, Garcia Villalba E, Alcaraz Garcia A, Alcaraz Garcia MJ, Munoz Perez A, Pinera Salmeron P, Bernal Morell E. Prognostic value of pro-adrenomedullin and NT-proBNP in patients referred from the emergency department with influenza syndrome. Emergencias. 2019 Jun;31(3):180-184. English, Spanish. PubMed PMID: 31210450.
AÑO: 2019; IF: 5.345
|
31601711